India moves closer to getting its first indigenous vaccine against dengue(PG 14)(GS 3)
•Drug makers Serum Institute of India and Panacea Biotec respond to call for Phase 3 clinical trials;
•according to a senior official, the trials, being done to evaluate efficacy,
safety and immunogenicity of vaccine, could start close to August